A second chance for avatrombopag in chemotherapy-induced thrombocytopenia

被引：0

作者：

Al-Samkari, Hanny ^{[1
,2
]}

Moore, Donald C. ^{[3
]}

机构：

[1] Massachusetts Gen Hosp, Div Hematol Oncol, Bartlett Hall Extens Off 133, Boston, MA 02114 USA

[2] Harvard Med Sch, Boston, MA USA

[3] Atrium Hlth, Levine Canc Inst, Dept Pharm, Charlotte, NC USA

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2025年 / 206卷 / 01期

关键词：

avatrombopag; chemotherapy-induced thrombocytopenia; persistent; romiplostim; thrombopoietin receptor agonist; ROMIPLOSTIM;

D O I：

10.1111/bjh.19861

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Chemotherapy-induced thrombocytopenia (CIT) remains a common complication of cancer therapy with no approved available treatments in most of the world. Although a prior clinical trial of avatrombopag for CIT did not meet its primary end-point, a report from Galamaga and colleagues raises prospects for a second chance for avatrombopag in CIT, highlighting the differences between nadir and persistent CIT and the importance of patient selection in CIT treatment.

引用

页码：375 / 377

页数：3

共 50 条

[21] Evaluation of the Efficacy of Romiplostim in Management of Chemotherapy-Induced Thrombocytopenia in Indian Patients: A Retrospective Study [J].

Talreja, Vikas ;

Khatwani, Sangeeta ;

Subhagan, Priyanka .

SOUTH ASIAN JOURNAL OF CANCER, 2025,

[22] Avatrombopag for chemotherapy-induced thrombocytopenia in patients with non-haematological malignancies: an international, randomised, double-blind, placebo-controlled, phase 3 trial [J].

Al-Samkari, Hanny ;

Kolb-Sielecki, Jaroslaw ;

Safina, Sufiia Z. ;

Xue, Xiaoqiang ;

Jamieson, Brian D. .

LANCET HAEMATOLOGY, 2022, 9 (03) :E179-E189

[23] Avatrombopag for the treatment of immune thrombocytopenia and thrombocytopenia of chronic liver disease [J].

Cheloff, Abraham Z. ;

Al-Samkari, Hanny .

JOURNAL OF BLOOD MEDICINE, 2019, 10 :313-321

[24] Thrombopoietin receptor agonists for chemotherapy-induced thrombocytopenia: a new solution for an old problem [J].

Al-Samkari, Hanny .

HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2022, (01) :286-295

[25] Avatrombopag for the Treatment of Immune Thrombocytopenia [J].

Labanca, Caterina ;

Vigna, Ernesto ;

Martino, Enrica Antonia ;

Bruzzese, Antonella ;

Mendicino, Francesco ;

Carida, Giulio ;

Lucia, Eugenio ;

Olivito, Virginia ;

Puccio, Noemi ;

Neri, Antonino ;

Morabito, Fortunato ;

Gentile, Massimo .

EUROPEAN JOURNAL OF HAEMATOLOGY, 2025, 114 (05) :733-746

[26] Management of chemotherapy-induced thrombocytopenia: guidance from the ISTH Subcommittee on Hemostasis and Malignancy [J].

Soff, Gerald ;

Leader, Avi ;

Al-Samkari, Hanny ;

Falanga, Anna ;

Maraveyas, Anthony ;

Sanfilippo, Kristen ;

Wang, Tzu-Fei ;

Zwicker, Jeffrey .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2024, 22 (01) :53-60

[27] Treatment of chemotherapy-induced thrombocytopenia with monotherapy versus combination therapy: the devil is in the details [J].

Al-Samkari, Hanny .

RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2023, 7 (08)

[28] Chemotherapy-induced thrombocytopenia and clinical bleeding in patients with gynecologic malignancy [J].

Hashiguchi, Y. ;

Fukuda, T. ;

Ichimura, T. ;

Matsumoto, Y. ;

Yasui, T. ;

Sumi, T. ;

Ishiko, O. .

EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2015, 36 (02) :168-173

[29] Thrombopoietin receptor agonist antibody for treating chemotherapy-induced thrombocytopenia [J].

Jiwon Shin ;

Min-Jung Kim ;

Xingguo Quan ;

Ji Woong Kim ;

Sukmook Lee ;

SaeGwang Park ;

Jee-Yeong Jeong ;

Kyungmoo Yea .

BMC Cancer, 23

[30] Thrombopoietin receptor agonists for prevention and treatment of chemotherapy-induced thrombocytopenia in patients with solid tumours [J].

Zhang, Xia ;

Chuai, Yunhai ;

Nie, Wei ;

Wang, Aiming ;

Dai, Guanghai .

COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (11)

← 1 2 3 4 5 →